These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

62 related articles for article (PubMed ID: 7375370)

  • 1. [Lymphoid leukemia with bone rarefaction due to juxtalymphocytic hyperosteoclastosis].
    Bonvoisin B; Bouvier M; Meunier PJ
    Nouv Presse Med; 1980 Apr; 9(18):1312. PubMed ID: 7375370
    [No Abstract]   [Full Text] [Related]  

  • 2. [On bone changes in lymphatic leukemia].
    ANDING E
    Z Orthop Ihre Grenzgeb; 1961 May; 94():412-9. PubMed ID: 13683319
    [No Abstract]   [Full Text] [Related]  

  • 3. [Osteo-marmoreal lymphomonocytic leukemia; based on 4 unpublished cases].
    GUICHARD A; PELLOUX H; BOURRAT C
    Lyon Med; 1957 Mar; 89(11):245-64. PubMed ID: 13429917
    [No Abstract]   [Full Text] [Related]  

  • 4. [Bone biopsy studies in lymphadenoses].
    PAPAGEORGIOU A; SCHMITT-ROHDE JM
    Dtsch Arch Klin Med; 1961; 207():394-411. PubMed ID: 14483677
    [No Abstract]   [Full Text] [Related]  

  • 5. [Changes in the osseous system in chronic manifest lymphatic leukemia].
    BRATKOWSKA-SENIOW B; KWIATKOWSKI S
    Pol Arch Med Wewn; 1959; 29():797-808. PubMed ID: 13803947
    [No Abstract]   [Full Text] [Related]  

  • 6. Bone sclerosis.
    N Y State J Med; 1971 May; 71(10):1095-7. PubMed ID: 5280685
    [No Abstract]   [Full Text] [Related]  

  • 7. The prognostic significance of bone and joint manifestations in childhood leukemia.
    Révész T; Kardos G; Kajtár P; Schuler D
    J Rheumatol; 1985 Jun; 12(3):647-8. PubMed ID: 3862848
    [No Abstract]   [Full Text] [Related]  

  • 8. [The prognostic value of bone involvement in childhood acute lymphoblastic leukaemia (author's transl)].
    Pastore G; Miniero R; Cordero di Montezemolo L; Felicioni V; Fiandino G; Grazia G; Morgando MP; Trada M; Madon E
    Haematologica; 1981 Dec; 66(6):750-5. PubMed ID: 6802716
    [No Abstract]   [Full Text] [Related]  

  • 9. The relative contribution of cysteine proteinases and matrix metalloproteinases to the resorption process in osteoclasts derived from long bone and scapula.
    Shorey S; Heersche JN; Manolson MF
    Bone; 2004 Oct; 35(4):909-17. PubMed ID: 15454098
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Prolymphocytic leukemia - case report].
    Hellmann A
    Acta Haematol Pol; 1981; 12(2):103-6. PubMed ID: 7304087
    [No Abstract]   [Full Text] [Related]  

  • 11. [The lymphocyte populations in chronic lymphoid leukemia and their response to splenic irradiation].
    Peckham MJ; Parmentier C
    Rev Fr Etud Clin Biol; 1968; 13(6):591-7. PubMed ID: 5724631
    [No Abstract]   [Full Text] [Related]  

  • 12. Osteoclast diseases.
    Helfrich MH
    Microsc Res Tech; 2003 Aug; 61(6):514-32. PubMed ID: 12879419
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Th17 functions as an osteoclastogenic helper T cell subset that links T cell activation and bone destruction.
    Sato K; Suematsu A; Okamoto K; Yamaguchi A; Morishita Y; Kadono Y; Tanaka S; Kodama T; Akira S; Iwakura Y; Cua DJ; Takayanagi H
    J Exp Med; 2006 Nov; 203(12):2673-82. PubMed ID: 17088434
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Lymphocyte viability in chronic lymphocytic leukemia in in vivo culture].
    Hansz J; Pytlak B; Drozdowska D
    Pol Arch Med Wewn; 1979 Sep; 62(3):215-20. PubMed ID: 523325
    [No Abstract]   [Full Text] [Related]  

  • 15. Involvement of subchondral bone marrow in rheumatoid arthritis: lymphoid neogenesis and in situ relationship to subchondral bone marrow osteoclast recruitment.
    Bugatti S; Caporali R; Manzo A; Vitolo B; Pitzalis C; Montecucco C
    Arthritis Rheum; 2005 Nov; 52(11):3448-59. PubMed ID: 16258900
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Phenotypic characteristics of bone in carbonic anhydrase II-deficient mice.
    Margolis DS; Szivek JA; Lai LW; Lien YH
    Calcif Tissue Int; 2008 Jan; 82(1):66-76. PubMed ID: 18175028
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The role of cell markers in the management of leukemia.
    Bowman WP; Mauer A
    Prog Hematol; 1981; 12():165-85. PubMed ID: 6175993
    [No Abstract]   [Full Text] [Related]  

  • 18. Macrophage migration inhibitory factor-deficient mice are resistant to ovariectomy-induced bone loss.
    Oshima S; Onodera S; Amizuka N; Li M; Irie K; Watanabe S; Koyama Y; Nishihira J; Yasuda K; Minami A
    FEBS Lett; 2006 Feb; 580(5):1251-6. PubMed ID: 16442103
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Bone involvement in chronic lymphoid leukemia. Apropos of a case].
    Meyer R; Kieffer D; Vautravers P; Kuntz JL; Asch L
    Rev Rhum Mal Osteoartic; 1980 Nov; 47(11):651-5. PubMed ID: 7444308
    [No Abstract]   [Full Text] [Related]  

  • 20. Cytotoxicity of a glycolytic enzyme inhibitor for immature lymphoid cells.
    Stuart J; Mann JR
    Br J Haematol; 1972 May; 22(5):633-4. PubMed ID: 4503795
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.